S Amiel
Thu 21 10:30
CMW4.1
Clinical Management Workshop 4: Managing Hypoglycaemia
Hypoglycaemia in diabetes - effects on cerebral and autonomic function
G Anderson
Wed 20 13:45
S12.1
Symposium 12: Thymic function and autoimmune endocrine disease
The thymus medulla, Aire, and autoimmunity
R Andrew
Edinburgh, UK
Wed 20
MTE9
Meet The Expert 9
Biomedical mass spectrometry - moving forward
Edinburgh, UK
W Arlt
Thu 21 09:45
CG1.2
Clinical Guidelines
Adults with CAH
S Aylwin
Wed 20 09:00
N1.1
Nurse Session 1: The Patient Pathway for Pituitary Care
Overview and workup
Dr John Ayuk
Birmingham, UK
Tue 19 08:35
CMW2.2
Clinical Management Workshop 2: How Do I Do It?
How do I investigate and manage hypomagnesaemia?
Birmingham, UK
A Balen
Thu 21 10:30
CMW3.1
Clinical Management Workshop 3: PCOS - why, how and what
Consensus on women's health aspects of PCOS
I Banerjee
Tue 19 09:35
CMW2.5
Clinical Management Workshop 2: How Do I Do It?
How and when do I induce puberty in males?
S Baron-Cohen
Mon 18 16:15
S5.1
Symposium 5: Sex in the brain
Foetal testosterone in mind
P Beck-Peccoz
Milan, Italy
Tue 19 15:00
S7.3
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Human thyroid hormone receptor beta mutations - syndrome of resistance to thyroid hormone
Milan, Italy
G Begum
Tue 19 14:45
OC4.3
Oral Communications 4: Obesity, metabolism and bone
Adult offspring of undernourished sheep exhibit epigenetic alterations in HPA axis glucocorticoid receptor
L Bentley
Mon 18 17:30
OC2.6
Oral Communications 2: Steroids and thyroid
An N-ethyl-N-nitrosourea induced Corticotrophin releasing hormone (Crh) promoter mutation provides a mouse model of Cushing’s syndrome
J Bevan
Tue 19 09:15
CMW2.4
Clinical Management Workshop 2: How Do I Do It?
How do I manage the pregnant patient with a prolactinoma?
Tue 19
Ipsen satellite symposium
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the PRIMARYS trial
Wed 20 10:30
EW2.5
Education Workshop 2: How to get your research published
Clinical Endocrinology
A Bianco
Miami, USA
Wed 20
PL5
BTA Pitt-Rivers Lecture
Regulation of Tissue-Specific Regulation of Thyroid Hormone Action
Miami, USA
Stephen Bloom
Wed 20 15:15
S11.4
Symposium 11: Guts, brains and bariatric surgery
Gut hormones: a cure for obesity
B Boucher
Thu 21 11:45
SE1.4
Senior Endocrinologists' Session
Vitamin D action on the Renin/Angiotensin system in pancreas and liver
G Brabant
Wed 20 14:25
N2.2
Nurse Session 2: Late Effects
Thyroid late effects
M Brandi
Florence, Italy
Mon 18 16:15
CMW1.1
Clinical Management Workshop 1: Management controversies in parathyroid disease
Hyperparathyroidism in MEN1
Florence, Italy
T Brue
Marseille, France
Tue 19 18:00
S8.4
Symposium 8: Non functioning pituitary tumours
Aggressive pituitary tumours and temozolomide treatment
Marseille, France
J Cegia
Tue 19 15:00
OC4.5
Oral Communications 4: Obesity, metabolism and bone
Energy intake following infusion of glucagon and GLP-1: a double-blind crossover study
T Cheetham
Tue 19 17:45
MTE5
Meet the Expert 5
Challenges in managing hyperthroidism in young people
D Chen
Mon 18 18:00
OC2.8
Oral Communications 2: Steroids and thyroid
When math meets biology: systems approach to drug resistance analysis
S Chen
Tue 19 08:30
OC3.2
Oral Communications 3: Reproduction, growth and development
Heterodimerisation of gonadotrophin hormone receptors modifies the LH-induced calcium signalling profile
S-Y Cheng
Bethesda, USA
Tue 19 15:30
S7.4
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Nuclear coregulators confer the actions of mutant thyroid hormone receptor alpha and beta
Bethesda, USA
J Christiansen
Aarhus, Denmark
Wed 20 10:00
EW2.1
Education Workshop 2: How to get your research published
Endocrine Connections
Aarhus, Denmark
S Cinti
Wed 20 09:00
S10.1
Symposium 10: Lipodystrophy - The perils of being thin
Familial partial lipodystrophy: an introduction
A Clark
Wed 20 10:20
EW2.3
Education Workshop 2: How to get your research published
Journal of Endocrinology
Wed 20 10:25
EW2.4
Education Workshop 2: How to get your research published
Journal of Molecular Endocrinology
A Comninos
Mon 18 15:30
OC1.8
Oral Communications 1: Young Endocrinologists's Prize Session
Kisspeptin advances ovulation in healthy women
J Connell
Tue 19
MTE3
Meet the Expert 3
Investigation of patients with suspected mineralocorticoid hypertension
G Conway
Tue 19
MTE1
Meet the Expert 1
Turner Syndrome / pregnancy / cardiac risk
B Conway-Campbell
Tue 19 08:45
S6.2
Symposium 6: Making the glucocorticoid clock run smoothly
Molecular dynamics of ultradian glucocorticoid receptor action
P Coskeran
Wed 20 10:45
N1.5
Nurse Session 1: The Patient Pathway for Pituitary Care
Post-operative and follow-up care
J Denes
Tue 19 16:45
OC5.2
Oral Communications 5: Pituitary and neoplasia
The role of the microRNA miR-34a in the regulation of aryl hydrocarbon receptor interacting protein (AIP)
Tue 19 18:15
OC5.8
Oral Communications 5: Pituitary and neoplasia
Pituitary adenoma and phaeochromocytoma/paraganglioma - a novel syndrome with a heterogeneous genetic background
T Dickmeis
Karlsruhe, Germany
Tue 19 08:15
S6.1
Symposium 6: Making the glucocorticoid clock run smoothly
Monitoring glucocorticoid signalling and circadian clock function with transgenic zebrafish reporter lines
Karlsruhe, Germany
S Dickson
Gothenburg, Sweden
Wed 20 14:15
S11.2
Symposium 11: Guts, brains and bariatric surgery
Gut-brain communication - Ghrelin
Gothenburg, Sweden
M Donaldson
Tue 19 09:55
CMW2.6
Clinical Management Workshop 2: How Do I Do It?
How do I - and how should I - induce puberty in females?
A Drakesmith
Mon 18 11:30
S1.2
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
The iron regulatory hormone hepcidin
S Driesche
Tue 19 09:15
OC3.5
Oral Communications 3: Reproduction, growth and development
Effects of in utero exposure to acetaminophen (paracetamol) on steroidogenesis by the rat and human fetal testis
Professor Maralyn Druce
London, UK
Wed 20 15:05
N2.3
Nurse Session 2: Late Effects
Gonadal late effects
London, UK
C Dulac
Cambridge, USA
Mon 18 17:15
S5.3
Symposium 5: Sex in the brain
Neuronal circuits underlying sex specific social behaviour
Cambridge, USA
R Duncan
Wed 20
MTE8
Meet The Expert 8
Live Cell Imaging
R Eastell
Mon 18 13:45
S4.1
Symposium 4: New Bone Biology - Is there life after RANK ligand?
New bone biology and Cathepsin K inhibitors
P Esbrit
Madrid, Spain
Mon 18 14:45
S4.3
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Parathyroid hormone related peptide as a potential treatment for osteoporosis
Madrid, Spain
H Escobar-Morreale
Madrid, Spain
Thu 21 12:00
CMW3.4
Clinical Management Workshop 3: PCOS - why, how and what
Diagnosis and Management of hirsuitism
Madrid, Spain
R Evans
La Jolla, USA
Mon 18 11:00
S1.1
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
Iron homeostasis: who are the major players?
La Jolla, USA
Tue 19
PL1
SfE Dale Medal Lecture
Nuclear receptors and AMPK: can exercise mimetics cure diabetes?
La Jolla, USA
P Foster
Tue 19 14:45
YE1.4
YE Symposium: Maintaining your endocrine career despite what life throws at you
Non-traditional career paths towards an acedemic career
R Fowkes
Mon 18 16:15
EW1.1
Education Workshop 1: Teaching and Learning in Endocrinology
Undergraduate research participation: going beyond 'students as producers'
J Franklyn
Tue 19 16:30
D1.1
Debate
FOR
W Fraser
Mon 18 16:45
CMW1.2
Clinical Management Workshop 1: Management controversies in parathyroid disease
Parathyroid hormone, vitamin D and chronic kidney disease
T Freeman
Mon 18 14:45
APW1.3
Applied Physiology Workshop
Analysis and visualisation of biological networks
C Gaston-Massuet
Mon 18 18:00
YEP1.2
Young Endocrinologists Prize Lectures
Pituitary development: the answer, is blowing in the Wnt
L Gathercole
Mon 18 14:30
OC1.4
Oral Communications 1: Young Endocrinologists's Prize Session
A Serum MicroRNA Profile Potentially Associated with Glucocorticoid Mediated Insulin Resistance
M Gershengorn
Bethesda, USA
Wed 20 09:30
S9.2
Symposium 9: Novel aspects of GPCR signalling
Novel aspects of TSH receptor signalling
Bethesda, USA
A Gogakos
Mon 18 17:00
OC2.4
Oral Communications 2: Steroids and thyroid
THRA or DIO2 mutations are not a common cause of high bone mass in humans
N Gordon
Wed 20 09:30
N1.2
Nurse Session 1: The Patient Pathway for Pituitary Care
Peri-operative care-surgical aspects
F Gribble
Wed 20 14:45
S11.3
Symposium 11: Guts, brains and bariatric surgery
Targeting gut hormone release to treat obesity
A Grossman
Tue 19
Ipsen satellite symposium
Stabilising tumour growth in patients with NETs
Wed 20
MTE 6
Meet the Expert 6
Malignant Phaeochromocytoma
Wed 20
Viropharma satellite symposium
Current challenges in the management of AI: goals of therapy
M Gurnell
Tue 19
Ipsen satellite symposium
Tumour response to presurgical lanreotide Autogel therapy in the ACROPAT trial
L Hand
Tue 19 10:00
OC3.8
Oral Communications 3: Reproduction, growth and development
Adiponectin induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages
N Hanley
Tue 19 16:30
MTE4
Meet The Expert 4
Induced plurripotent stem cells as an endocrine tool
P Hannaert
Poitiers, France
Mon 18 15:15
APW1.4
Applied Physiology Workshop
Modelling the circulating renin-angiotensin system and its efefcts on blood pressure
Poitiers, France
R Hardy
Tue 19 09:45
OC3.7
Oral Communications 3: Reproduction, growth and development
Disruption of Mesenchymal Glucocorticoid Signaling Attenuates Embryonic Lung Development and Results in Post Natal Lethality in Mice
Z Hassan-Smith
Mon 18 14:15
OC1.3
Oral Communications 1: Young Endocrinologists's Prize Session
11β-HSD1KO mice are protected from glucocorticoid dependent age-associated muscle atrophy
R Holt
Wed 20 07:15
MTE7
Meet the Expert 7
Hormone misuse in sport and leisure
D Hosking
Mon 18 17:45
CMW1.4
Clinical Management Workshop 1: Management controversies in parathyroid disease
Medical management of parathyroid disease
S Howles
Mon 18 15:15
OC1.7
Oral Communications 1: Young Endocrinologists's Prize Session
Autosomal dominant hypocalcemia type 2 is caused by germline GNA11 gain-of-function mutations
T Howlett
Tue 19 14:30
YE1.3
YE Symposium: Maintaining your endocrine career despite what life throws at you
Getting useful research results from routine NHS activity
I Huhtaniemi
Wed 20 10:00
S9.3
Symposium 9: Novel aspects of GPCR signalling
In vivo dimerization of LH receptors
K Hussain
Thu 21 11:30
CMW4.3
Clinical Management Workshop 4: Managing Hypoglycaemia
Hypoglycaemia in neonates and children
L Ibanez
Barcelona, Spain
Thu 21 11:00
CMW3.2
Clinical Management Workshop 3: PCOS - why, how and what
Treatment of PCOS in Non-Obese Adolescents
Barcelona, Spain
S Jamal
Toronto, Canada
Mon 18 15:15
S4.4
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Organic nitrates for the treatment of postmenopausal osteoporosis
Toronto, Canada
N James
Tue 19 08:15
CMW2.1
Clinical Management Workshop 2: How Do I Do It?
How do I manage testosterone replacement after prostate cancer therapy?
F Jean-Alphonse
Tue 19 08:15
OC3.1
Oral Communications 3: Reproduction, growth and development
Identification of very early sorting endosomes that spatially program gonadotrophin hormone receptor signalling
G Johannsson
Gothenburg, Sweden
Wed 20
Viropharma satellite symposium
How a dual-release preparation can help overcome challenges
Gothenburg, Sweden
Dr Kim Jonas
London, UK
Tue 19 08:45
OC3.3
Oral Communications 3: Reproduction, growth and development
Regulation of G protein-coupling specificity via cis and trans activation of the luteinising hormone/chorionic gonadotrophin receptor (LHCGR)
London, UK
U Kaiser
Boston, USA
Wed 20 09:00
S9.1
Symposium 9: Novel aspects of GPCR signalling
GPCR mutations and reproduction
Boston, USA
Niki Karavitaki
Birmingham, UK
Tue 19 16:30
S8.1
Symposium 8: Non functioning pituitary tumours
Epidemiology and natural history of pituitary tumours
Birmingham, UK
E Keverne
Mon 18 16:45
S5.2
Symposium 5: Sex in the brain
Importance of genomic imprinting in the evolution and development of the maternal brain
C Koppen
Saarbrucken, Germany
Wed 20 10:30
S9.4
Symposium 9: Novel aspects of GPCR signalling
Allosteric LH receptor regulation
Saarbrucken, Germany
Professor Márta Korbonits
London, UK
Wed 20
PL6
SfE Medal Lecture
Genes and Giants

Unknown speaker

London, UK
O Koulouri
Tue 19 17:15
OC5.4
Oral Communications 5: Pituitary and neoplasia
Clinical, metabolic, biochemical and radiological characterisation of patients with thyrotropinomas reveals a highly variable phenotype
F Labrie
Quebec, Canada
Tue 19
PL2
SfE Hoffenberg International Medal Lecture
Multiple applications of intracrinology in clinical medicine
Quebec, Canada
D Landau
Wed 20 10:15
N1.4
Nurse Session 1: The Patient Pathway for Pituitary Care
Radiotherapy and post operative management
S Larkin
Tue 19 17:30
OC5.5
Oral Communications 5: Pituitary and neoplasia
Densely and sparsely granulated somatotroph adenomas - clinical, genetic and histological differences
G Lavery
Tue 19 14:00
YE1.1
YE Symposium: Maintaining your endocrine career despite what life throws at you
Maintaining an active basic research career whilst juggling an academic and personal life
J Lazarus
Thu 21 10:30
SE1.1
Senior Endocrinologists' Session
The UK is an underdeveloped country - The Iodine Scandal
G Leese
Mon 18 17:15
CMW1.3
Clinical Management Workshop 1: Management controversies in parathyroid disease
'Mild hyperparathyroidism' - what determines clinical outcome?
R Legro
Hershey, USA
Thu 21 11:30
CMW3.3
Clinical Management Workshop 3: PCOS - why, how and what
Is there a place for Metformin in PCOS?
Hershey, USA
G Leng
Mon 18 13:45
APW1.1
Applied Physiology Workshop
Modelling neuroendocrine systems
M Levy
Mon 18 17:15
EW1.3
Education Workshop 1: Teaching and Learning in Endocrinology
Recommended standards for undergraduate medical education
S Lightman
Thu 21
PL7
Clincal Endocrinology Trust Lecture
The dynamics of hypothalamic-pituitary-adrenal activity
K Lines
Tue 19 16:30
OC5.1
Oral Communications 5: Pituitary and neoplasia
Genetic background influences tumour phenotype in heterozygous Men1 knockout mice
D Livingstone
Tue 19 15:15
OC4.6
Oral Communications 4: Obesity, metabolism and bone
Transgenic disruption of 5alpha-reductase1 increases susceptibility to liver fibrosis
L Lumey
Columbia, USA
Mon 18 12:00
S3.3
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Epigenetic differences associated with prenatal exposure to famine in humans
Columbia, USA
A Madathil
Mon 18 16:30
OC2.2
Oral Communications 2: Steroids and thyroid
Abnormal cardiac bio-energetics in subclinical hypothyroidism; cardiac magnetic resonance spectroscopic study
V Marks
Thu 21 12:35
SE1.6
Senior Endocrinologists' Session
Suspicious hypoglycaemia: was it insulin?
J McKenna
Dublin, Ireland
Thu 21 10:55
SE1.2
Senior Endocrinologists' Session
Robert Graves and his remarkable colleagues
Dublin, Ireland
M Meaney
Montreal, Canada
Wed 20
PL4
SfE Translatlantic Medal Lecture
Environmental regulation of neuroendocrine systems through epigenetic mechanisms
Montreal, Canada
S Morgan
Tue 19 14:15
OC4.2
Oral Communications 4: Obesity, metabolism and bone
11β-HSD1 Knockout Mice are Protected from the Adverse Metabolic Effects of Exogenous Glucocorticoid Excess
Dr Robert Murray
Leeds, UK
Wed 20 13:45
N2.1
Nurse Session 2: Late Effects
Pituitary late effects
Leeds, UK
D Nanus
Mon 18 13:45
OC1.1
Oral Communications 1: Young Endocrinologists's Prize Session
TNFα directly regulates in vivo corticosteroid metabolism in inflammatory arthritis
S Nef
Geneva, Switzerland
Mon 18 11:30
S2.2
Symposium 2: Hormones Maketh Man
The role of the Sertoli cell in driving 'maleness'
Geneva, Switzerland
A Nesbit
Tue 19 15:30
OC4.7
Oral Communications 4: Obesity, metabolism and bone
Familial Hypocalciuric Hypercalcaemia Type 3 (FHH3) is Caused by Mutations in Adaptor Protein 2 Sigma 1 (AP2S1)
Dr Paul Newey
Dundee, United Kingdom
Tue 19 14:15
YE1.2
YE Symposium: Maintaining your endocrine career despite what life throws at you
Juggling a clinical workload: and academic research
Dundee, United Kingdom
Tue 19 17:00
OC5.3
Oral Communications 5: Pituitary and neoplasia
Whole-exome sequencing studies of non-functioning pituitary adenomas
Dundee, United Kingdom
L Nieman
Bethesda, USA
Thu 21
PL8
Clinical Endocrinology Trust Visiting Professor Lecture
Evaluation of the adrenal cortex: Future possibilities
Bethesda, USA
E Nieschlag
Muenster, Germany
Thu 21 11:20
SE1.3
Senior Endocrinologists' Session
Should the Aging Male Become a Father?
Muenster, Germany
G Papacleovaulou
Tue 19 14:45
OC4.4
Oral Communications 4: Obesity, metabolism and bone
Cholestatic pregnancy programmes metabolic disease in the offspring
S Papapoulos
Leiden, The Netherlands
Mon 18 14:15
S4.2
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Inhibition of sclerostin in the treatment of osteoporosis
Leiden, The Netherlands
S Pearce
Newcastle, UK
Tue 19 09:45
S6.4
Symposium 6: Making the glucocorticoid clock run smoothly
Retraining the HPA axis: how to cure adrenal insufficiency
Newcastle, UK
K Perry
Tue 19 15:00
YE1.5
YE Symposium: Maintaining your endocrine career despite what life throws at you
Re-establishing your research profile after a career break (academic perspective)
P Peterson
Wed 20 14:15
S12.2
Symposium 12: Thymic function and autoimmune endocrine disease
Anti-cytokine autoantibodies in AIRE deficient humans and mice
D Pfaff
New York, USA
Mon 18 17:45
S5.4
Symposium 5: Sex in the brain
Hormone-dependent chromatin modifications regulating sexually differentiated animal behaviour
New York, USA
P Prasad
Mon 18 17:15
OC2.5
Oral Communications 2: Steroids and thyroid
A mutation in thioredoxin reductase 2 (TXNRD2) is associated with a predominantly adrenal phenotype in humans
V Rakyan
Mon 18 11:00
S3.1
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Epigenome-wide association studies for common human diseases
R Rey
Buenos Aires, Argentina
Mon 18 11:00
S2.1
Symposium 2: Hormones Maketh Man
Anti-müllerian hormone - a Sertoli cell hormone that can be used as a predictor of male hypogonadism
Buenos Aires, Argentina
R Richardson
Tue 19 14:00
OC4.1
Oral Communications 4: Obesity, metabolism and bone
Glucocorticoid receptor deficiency in cardiomyocytes causes pathological cardiac remodelling in mice.
R Robertson
Tue 19 09:30
OC3.6
Oral Communications 3: Reproduction, growth and development
Follistatin-Like 3 (FSTL3), a transforming growth factor β (TGFβ) ligand inhibitor, is essential for placental development in mice.
M Rodie
Tue 19 09:00
OC3.4
Oral Communications 3: Reproduction, growth and development
Characterising changes in the in vivo male rodent brain using Magnetic Resonance Spectroscopy
M Rodriguez-Fernandez
Santa Barbara, USA
Mon 18 14:15
APW1.2
Applied Physiology Workshop
Distinguishing normal, depressive and PTSD cortisol dynamics in humans through mathematical modelling
Santa Barbara, USA
R Ross
Tue 19 09:15
S6.3
Symposium 6: Making the glucocorticoid clock run smoothly
Diurnal cortisol delivery: a novel tool for adrenal insufficiency
C Roux
Wed 20 13:45
S11.1
Symposium 11: Guts, brains and bariatric surgery
How does bariatric surgery cure obesity?
G Ryan
Mon 18 16:45
OC2.3
Oral Communications 2: Steroids and thyroid
A bi-transgenic murine model of PTTG and PBF overexpression in the thyroid gland
D Sansom
Wed 20 15:15
S12.4
Symposium 12: Thymic function and autoimmune endocrine disease
Regulatory T cells, CTLA-4 and autoimmune disease
P Saunders
Tue 19 15:15
YE1.6
YE Symposium: Maintaining your endocrine career despite what life throws at you
Putting your best foot forward - what the funders' are looking for
D Savage
Wed 20 09:30
S10.2
Symposium 10: Lipodystrophy - The perils of being thin
Novel genetic causes of partial lipdystrophy
N Schoenmakers
Mon 18 16:15
OC2.1
Oral Communications 2: Steroids and thyroid
Loss-of-Function Mutations in IGSF1 Cause a Novel, X-Linked Syndrome of Central Hypothyroidism and Testicular Enlargement
L Seal
Tue 19 08:55
CMW2.3
Clinical Management Workshop 2: How Do I Do It?
How do I monitor and follow up transgender patients using hormonal therapies?
P Selby
Mon 18 17:45
EW1.4
Education Workshop 1: Teaching and Learning in Endocrinology
Postgraduate training in endocrinolgoy and diabetes - developing the curriculum and assessments
Dr Robert Semple
UK
Thu 21 12:00
CMW4.4
Clinical Management Workshop 4: Managing Hypoglycaemia
Autoimmune hypoglycaemia - when and how to look for anti-insulin and anti-insulin receptor antibodies
UK
J Service
Rochester, USA
Thu 21 11:00
CMW4.2
Clinical Management Workshop 4: Managing Hypoglycaemia
Insulinoma - new developments in localisation and therapy
Rochester, USA
A Sinha
Mon 18 15:00
OC1.6
Oral Communications 1: Young Endocrinologists's Prize Session
Improving the Vitamin D status of Vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle
L Smith
Mon 18 12:00
S2.3
Symposium 2: Hormones Maketh Man
Androgens and male fertility - a long way from the black box theory
V Smith
Tue 19 17:45
OC5.6
Oral Communications 5: Pituitary and neoplasia
Manipulating PBF/PTTG1IP phosphorylation status to improve radioiodine uptake in thyroid and other tumours
A Spada
Milan, Italy on behalf of the author group
Wed 20
PL3
SfE European Medal Lecture
cAMP in the pituitary: An old messenger for multiple signals
Milan, Italy on behalf of the author group
A Stears
Wed 20 10:30
S10.4
Symposium 10: Lipodystrophy - The perils of being thin
Approach to lipodystrophy management - a new national service
P Stewart
Birmingham, UK
Wed 20
Viropharma satellite symposium
Current challenges in the management of AI: why current therapy fails our patients
Birmingham, UK
Y Takahama
Tokushima, Japan
Wed 20 14:45
S12.3
Symposium 12: Thymic function and autoimmune endocrine disease
Attacking the endocrine system: what is AIRE doing?
Tokushima, Japan
G Tan
Tue 19
MTE2
Meet the Expert 2
Diabetes metellitus, endocrinology and the impact of GP commissioning
N Thomas
Wed 20 09:45
N1.3
Nurse Session 1: The Patient Pathway for Pituitary Care
The Surgery
A Tiganescu
Mon 18 17:45
OC2.7
Oral Communications 2: Steroids and thyroid
11β-hydroxysteroid dehydrogenase type 1: A role in skin wound healing
R Upreti
Mon 18 14:45
OC1.5
Oral Communications 1: Young Endocrinologists's Prize Session
Inhibition of 5α-reductase type 1 with dutasteride impairs insulin sensitivity
F Villarroya
Barcelona, Spain
Wed 20 10:00
S10.3
Symposium 10: Lipodystrophy - The perils of being thin
HIV and lipodystrophy
Barcelona, Spain
G Walls
Mon 18 18:00
YEP1.1
Young Endocrinologists Prize Lectures
Clinical and pre-clinical studies of neuroendocrine tumours (NETs) in Multiple Endocrine Neoplasia type 1 (MEN1), and evaluation of MEN1 gene replacement therapy for MEN1-associated NETs.
Tue 19 18:00
OC5.7
Oral Communications 5: Pituitary and neoplasia
Uterine tumours with loss of progesterone receptor expression develop in mice deleted for a Cell Division Cycle 73 (CDC73) allele
J Wass
Thu 21 09:30
CG1.1
Clinical Guidelines
Consequences of cancer therapy
F Weber
Essen, Germany
Wed 20 10:10
EW2.2
Education Workshop 2: How to get your research published
Endocrine-Related Cancer
Essen, Germany
A Weetman
Tue 19 17:00
D1.2
Debate
AGAINST
Anne White
Manchester, UK
Mon 18 11:30
S3.2
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Nutritional programming of epigenetics in metabolic syndrome
Manchester, UK
M Wierman
Denver, USA
Tue 19 17:00
S8.2
Symposium 8: Non functioning pituitary tumours
Pathological mechanisms underlying non-functioning pituitary tumours
Denver, USA
T Wilkin
Thu 21 12:10
SE1.5
Senior Endocrinologists' Session
Type 1 and Type 2 Diabetes are the same disorder of insulin resistance, but with different genetic backgrounds
G Williams
Tue 19 14:00
S7.1
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Physiologically distinct roles for thyroid hormone receptor isoforms
D Wood
Mon 18 16:45
EW1.2
Education Workshop 1: Teaching and Learning in Endocrinology
Clinical skills delivery
M Zatelli
Ferrara, Italy
Tue 19 17:30
S8.3
Symposium 8: Non functioning pituitary tumours
Pathological markers of aggressive pituitary tumour behaviour - use of MGMT?
Ferrara, Italy
Z Zhang
Mon 18 14:00
OC1.2
Oral Communications 1: Young Endocrinologists's Prize Session
Macrophage-specific 11β-hydroxysteroid dehydrogenase type 1 deficiency promotes angiogenesis but impairs resolution of K/BxN serum induced arthritis
H Zoller
Innsbruck, Austria
Mon 18 12:00
S1.3
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
'The Celtic disease' - haemochromatosis: a disease of iron overload
Innsbruck, Austria
P203
Evaluation of efficacy of transdermal delivery of chloroquine on Plasmodium berghei-infected male Sprague-Dawley rats and effects on  blood glucose and  renal electrolyte handling
Cephas T Murabayane
P206
ILEAL INTERPOSITION WITH DIVERTED SLEEVE GASTRECTOMY FOR TREATMENT OF TYPE 2 DIABETES
SUNIL KUMAR KOTA
P198
INFLAMMATORY MARKERS IN DIABETIC FOOT AND IMPACT OF VITAMIN D DEFICIENCY
SUNIL KUMAR KOTA
P207
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.
Hassan Kahal
P227
Short term calorie restriction : Effects on endocrine markers of nutritional status.
Swati Jain
P243
Re-occurrence of pancreatic insulinoma: an usual cause of hypoglycaemia
Charles Anwuzia-Iwegbu
P199
The Possible Involvement of the Receptor for Advanced Glycation End Products (RAGE) in Vascular Senescence in Diabetes
Nalinie Joharatnam
P236
Improvement in Testosterone post Bariatric surgery
Vani Shankaran
P228
The development of a structured education programme to improve cardiovascular risk in women with Polycystic Ovary Syndrome (SUCCESS Study)
Hamidreza Mani
P200
Effects of Syzygium aromaticum-derived oleanolic acid administration on postprandial glucose concentration and key intestinal carbohydrate hydrolyzing enzymes of streptozotocin-induced diabetic rats
Cephas T Musabayane
P241
Unusual case of Hypoglycaemia in diabetic patient
Aye Nyunt
P229
Hypogonadism in males with Type 2 Diabetes Mellitus
Adewole Adesanya
P183
The effects of Syzygium aromaticum-derived oleanolic acid on reactive oxygen species in the heart, liver and kidney of STZ-induced diabetic rats
Cephas T Musabayane
P208
Leptin in serum and vitreous humor, and retinal ob mRNA, in human diabetes.
Syed A Imran
P205
Irisin as a central regulator in energy homeostasis?
Milan K Piya
P230
Obesity-related hypogonadotrophic hypogonadism: recovery of normal pituitary-gonadal axis function following bariatric surgery
Anjali Santhakumar
P212
The Public distress domain of Quality of Life correlates directly and independently with BMI in pre-operative morbidly obese patients awaiting metabolic surgery
SYED ABDUS SABOOR AFTAB
P239
Preoperative characteristics of morbidly obese patients who achieved at least fifty percent excess weight loss post-metabolic Surgery
SYED ABDUS SABOOR AFTAB
P202
Vitamin D and insulin resistance: No association in healthy overweight people at high risk of cardiovascular disease.
Ian Wallace
P218
Weight loss after bariatric surgery in women of childbearing age
Aderinsola Alatishe
P213
Pregestational Body Mass Index Predicts Neonatal Hypoglycemia in Women with Gestational Diabetes
Ayesha Ahmad
P231
Risk Assessment of Adult Residents in Ile-Ife, South-Western Nigeria for Type 2 Diabetes Mellitus
Gbadebo Ajani
P184
Effects of Vitamin D supplementation on blood pressure, glucocorticoids and cardiovascular risk markers in healthy subjects
EMAD AL-DUJAILI
P219
Eating more quickly heightens overall systemic exposure to glucose and NEFA in the post-prandial phase, irrespective of energy expenditure in obese women
Thomas M Barber
P214
Effectiveness of bariatric surgery in women with and without polycystic ovarian syndrome
Angelos Kyriacou
P240
Glycaemic variability- does it make a difference in prediabetes?
Thomas Paul
P188
Human Abdominal Subcutaneous adipocytes as an active source of LpPLA2, influenced by fat depot and metabolic state, with LpPLA2 converting LDL into more potent atherogenic Ox-LDL, in vitro
Warunee Kumsaiyai
P232
Adrenal insufficiency post bariatric surgery
VANI SHANKARAN
P189
The role of glucocorticoid metabolism in bile acid homeostasis
Monica Naomi opiyo
P185
Knockdown of brain 11β-HSD1 does not lower body weight or improve insulin sensitivity
Erika Harno
P225
Non-Alcoholic Fatty Liver Disease in Patients Attending the National Severe Insulin Resistance Service.
Sarah M Leiter
P215
Octreotide therapy of chronic urticaria and angioedema after gastric bypass procedure
Jeanny Varghese
P220
Hepatic 11 ß-Hydroxysteroid Dehydrogenase Type 1 (11 ß-HSD1) is elevated following weight loss secondary to bariatric surgery.
Conor Woods
P237
Prevalence and Associated Risks for Metabolic Syndrome in Nigerians with Type 2 Diabetes Mellitus
David Soyoye
P209
The endocrine and metabolic characteristics of a large Bardet-Biedl syndrome clinic population
Safa Mujahid
P233
Pregnancy Outcome in a patient with Lipodystrophy and Type 2 Diabetes
Tolulope Shonibare
P180
A component of transcriptional PRC2 complex, enhancer of zest homology (EZH2), modulates endothelial cell responses to hypoxia and post-ischemic angiogenesis in a mouse model of limb ischemia
Tijana Mitic
P177
Association of calcium-sensing receptor polymorphisms with vascular calcification and glucose homeostasis in renal transplant recipients
Valerie N. Babinsky
P221
Brown adipose tissue identification in an adult human using IDEAL MRI
Narendra Reddy
P242
withdrawing insulin in a young person
mithun bhartia
P211
The Use of GLP-1 Receptor agonists to manage unwanted weight gain in patients with "Hypothalamic" obesity secondary to structural pituitary pathology 
Ye Kyaw
P238
ETHNIC SPECIFIC VALUES OF ANTHROPOMETRY IN A COASTAL NIGERIAN CITY
Ofem Enang
P204
Altered mitochondrial dynamics in obesity: redressing the balance through bariatric surgery?
Ciara McCarthy
P216
Prevalence of vitamin D insufficiency in severely obese patients seeking bariatric surgery
Rachel Smith
P194
Intracellular delivery of therapeutic siRNA via an Antennapedia-double stranded RNA Binding Domain Fusion protein as a novel strategy for PTP1B attenuation in Type 2 Diabetes
Myrsini Tsimon
P195
Replication of Genome Wide Association-Validated Loci for Type 2 Diabetes Mellitus in the Saudi Arabian Population
Nasser Al-Daghri
P222
Vitamin D Supplementation as Influenced by Diabetic Therapies
Nasser Al-Daghri
P178
Testosterone stimulates cholesterol efflux and metabolism in human macrophages via Liver X Receptor
Elizabeth Kilby
P190
Testosterone differentially regulates lipid and glucose metabolism in visceral and subcutaneous fat in the testicular feminised mouse
Daniel Kelly
P179
FGF21 action on human adipose tissue compromised by reduced BetaKlotho and FGFR1 expression in type 2 diabetes mellitus
Milan K Piya
P191
Novel inositol pyrophosphate (IP7) and insulin sensitivity (S<sub>I</sub><sup>2<sub>*</sub></sup>)in response to muscle contraction in glucose intolerant humans.
Jane Naufahu
P181
The Role of Hepatic 11β-Hydroxysteroid Dehydrogenase Type I in Cholesterol Homeostasis
Kajal Manwani
P235
What lies beneath: A case of spontaneous hypoglycaemia or glucose transporter type 1 defect disguised as chronic fatigue?
Mohit Kumar
P186
C-type natriuretic peptide (CNP) down regulates interferon gamma mediated pro-inflammatory gene expression in human endothelium
Charlotte Lawson
P192
Augurin stimulates food intake in male Wistar rats
Michael Patterson
P210
Maternal B12 insufficiency predicts neonate's metabolic risk factors
ANTONYSUNIL ADAIKALAKOTESWARI
P196
Cellular Consequences for Insulin Signal Transduction of the Naturally Occurring AKT2 p.Glu17Lys Mutation
Marina Minic
P223
Association of the Incidence of Type 1 diabetes with markers of infection and antibiotic susceptibility at country level
Alexia-Giovanna Abela
P182
Vitamin B12 and folate imbalance induces cholesterol synthesis and endoplasmic reticulum stress in human adipocytes
ANTONYSUNIL ADAIKALAKOTESWARI
P197
DPPIV and macronutrients regulate the expression of PYY3-36 in human gut epithelial cells.
Mohammed Gulrez Zariwala
P201
Unfolded protein response (UPR) pathway, IRE1α-XBP1 is altered during adipogenesis in obese human adipocytes
Philip Voyias
P193
Lipid profile changes in adipose tissue as a predictor of aging and inflammation in commercial pigs.
Hernan Pablo Fainberg
P187
Acute effects of co-infusion of Peptide YY(3-36) and Glucagon-like Peptide-1 on insulin secretion and insulin sensitivity
Rachel Troke
P224
A Pilot Study of 25-Hydroxy (25 - OH) Vitamin D Level in Type 2 Diabetes Mellitus with Diabetic Retinopathy
MONA ABDELSALAM
P234
Impaired iron status in severely obese bariatric surgery candidates is multifactorial
Rachel Smith
P217
Appetite regulation during a six-month military tour to Afghanistan
NE Hill
P226
A Study of Serum Osteocalcin Level in Women with Gestational Diabetes Mellitus
MONA ABDELSALAM
P30
Cinacalcet treatment for hypercalcaemia in primary hyperparathyroidism 
Ian Seetho
P15
PRIMARY HYPERPARATHYROIDISM IN PATIENTS WITH UROLITHIASIS: PREVALENCE AND PREDICTORS
SUNIL KUMAR KOTA
P9
BONE HEALTH IN TYPE 1 DIABETES PATIENTS WITH CELIAC DISEASE
SUNIL KUMAR KOTA
P11
BONE HEALTH IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
SUNIL KUMAR KOTA
P12
VITAMIN D RECEPTOR POLYMORPHISMS AND BONE MASS INDICES IN POST MENARCHEAL INDIAN ADOLESCENT GIRLS
SUNIL KUMAR KOTA
P14
BONE MASS ACCRUAL FOLLOWING SUPPLEMENTATION OF VITAMIN D ALONE VERSUS VITAMIN D + CALCIUM IN UNDERPRIVILEGED INDIAN PREMENARCHEAL GIRLS
SUNIL KUMAR KOTA
P8
Excessive growth hormone expression in bGH transgenic mice adversely alters bone architecture and quality
Su-Vern Lim
P7
Alterations of CLC-5 expression, function and trafficking in Dent’s disease
Caroline Gorvin
P3
Mutations in CLC-5 cause disturbances in cytoskeletal dynamics and solute transport in Dent’s disease renal proximal tubule cell-lines
Caroline Gorvin
P13
Identification of a Novel Heterozygous Mutation in Exon 50 of the COL1A1 Gene Manifesting Clinically as Osteogenesis Imperfecta
Thomas M Barber
P25
Proximal Myopathy: A diagnostic dilemma
Akshatha Taranath Kamath
P31
AUDIT of patients referred for DXA scanning in a south Indian Tertiary care centre
Thomas Paul
P26
Audit of Primary Hyperparathyroidism management: Do we adhere to the guidelines?
Prashanth Vas
P27
THE DIAGNOSIS OF OSTEOPOROSIS AMONG SUBJECTS OF SOUTHERN INDIAN ORIGIN ABOVE 50 YEARS OF AGE  – THE IMPACT OF THE INDIAN COUNCIL OF MEDICAL RESEARCH VERSUS CAUCASIAN BONE MINERAL DENSITY REFERENCE STANDARDS
Thomas Paul
P17
Risperidone associated changes in Prolactin and Bone mineral density: A study from South India
Thomas Paul
P33
Osteogenic malignancy and severe vitamin D deficiency (Osteogenic Osteomalacia)
Carol Postlethwaite
P22
Renal replacement therapy to treat severe hypercalcaemic crisis: Case series
Julia Prague
P28
Not the end of brown tumours - three cases within 12 months
Fred McElwaine
P23
Audit of cost-saving following introduction of investigation protocol for primary hyperparathyroidism
Christopher Smith
P20
Metabolic sydrome in women with osteoporosis on bisphosphonate therapy
Milica Marjanovic Petkovic
P1
GNA11 loss-of-function mutations cause familial hypocalciuric hypercalcaemia type 2 (FHH2)
Fadil Hannan
P10
High throughput detection of early joint pathology in mouse models of osteoarthritis
AE Draghici
P4
Contribution to bone mass and strength of osteoblast GH actions that are independent of local IGF-I production:  Lessons from the SOCS2 knockout mouse.
Ross Dobie
P21
The utility of neck MRI in the localisation of parathyroid adenomas in primary hyperparathyroidism
Nigel Glynn
P2
Increased linear bone growth in SOCS2 knockout mice in response to GH is independent of systemic or local IGF-1.
Ross Dobie
P5
Mimicking osteocytes <em>in vivo </em>using 3D collagen gels - development of a novel tool to study osteocyte biology
Nicole Scully
P18
Predictors of low bone mineral density in an Irish cystic fibrosis (CF) cohort
Tom McEnery
P32
Audit of management of patients with primary hyperparathyroidism in district general hospital
Funke Akiboye
P19
Comparison of Different Measures of Urinary Calcium excretion in Primary Hyperparathyroidism
Christopher Smith
P34
Osteogenic malignancy and severe vitamin D deficiency (Osteogenic Osteomalacia)
Carol Postlethwaite
P16
Impact of hyponatraemia in patients with fracture neck of femur
Jayadave Shakher
P29
A case of severe Immobilization Hypercacemia  ( IH ) in a young patient on Neurorehabilitation Unit.
Ahmad Shiraz
P6
Retinoic acid and IGF-1 stimulate the differentiation of human primary osteoblasts to osteocytes in 3D collagen gels
Sarah Goring
P24
Effect of Bone Mineral Density in Patients with Non- Functioning Pituitary Adenoma
Aye Aye Min
P155
Mechanisms of estrogen receptor function in breast cancer
Jason Carroll
P162
PREVALENCE OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 SYNDROME IN PRIMARY HYPERPARATHYROIDISM
SUNIL KUMAR KOTA
P174
A case of Hyperparathyroid Jaw Tumour Syndrome
Pranav Kumar
P159
The relationship between anatomical location of phaeochromocytoma and paraganglioma and their secretory properties
Chung Thong Lim
P170
Cowden Syndrome
Aye Naing
P163
Primary Thyroid Cancer as late effects of childhood cancer therapy: A case series of 5 patients
Manohara Kenchaiah
P161
Multi-modal approach to treatment in advanced adrenocortical carcinoma
Lesley Hall
P149
Epigenetic modifiers reduce proliferation of human neuroendocrine tumour cell lines
Kate. E Lines
P156
Investigation of the antiproliferative effect of natural sesquiterpene lactones on human cancer cell lines
Judit Molnár
P151
Phenotype- Genotype Analysis in a Cohort of Patients with Multiple Endocrine Neoplasia Type 1 (MEN1) Identifies a Novel Nonsense Mutation at Codon 554
Snigdha Reddy
P171
Recurrent bronchial carcinoid tumour presenting as a thyroid nodule
Lesley Hall
P160
Adjuvant use of <sup>131</sup>I-MIBG in phaeochromocytoma and paraganglioma at high risk of malignancy
Matthew A Rutherford
P164
Diagnosis, Localisation and Management of Insulinoma; a Single Centre Experience
Andrew S Powlson
P165
An Audit of Patients with Multiple Endocrine Neoplasia Type 1 in a Tertiary Referral Centre
Calum Goudie
P152
Parathyroid gland studies in mouse models for endocrine tumours defines anatomical locations and ultrastructural differences between normal and tumour cells.
Gerard Walls
P168
Review of patients with Adrenocortical carcinoma at a tertiary referral centre
S Deshpande
P158
Pituitary metasases: patients presenting with cranial nerve palsies and diabetes insipidus. A single centre experience.
Paola Salaris
P153
Functional induction of the oestrogen-regulated PTTG1-Binding Factor (PBF) in colorectal cancer
Perkin Kwan
P157
Predicted NES in PBF appears to be functional in vitro
Vikki Poole
P154
PBF overexpression causes increased p53 ubiquitination and degradation via MDM2
Gavin Ryan
P172
Gut carcinoid in a patient with horseshoe kidney and family history of carcinoid syndrome; a case report.
Konstantinos Lois
P150
POMC correlates with viable tumour cell mass in lung cancer xenografts
Jennifer Bryant
P166
Difficulties in management of malignant insulinoma
AM Rathore
P167
Crizotinib induced hypogonadism – a novel complication of lung cancer treatment
Thein Htay
P169
Between genetics, guidelines and treatment in MEN2A - a family affair
Ruxandra Dobrescu
P173
Insulinoma in postprandial hypoglycaemia and aggressive behaviour
Shwe Zin Chit Pan
P288
INFLAMMATORY MARKERS IN POLYCYSTIC OVARIAN SYNDROME AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS
SUNIL KUMAR KOTA
P290
BMP4 induces terminal differentiation of primary trophoblast cells and increases chorionic gonadotrophin secretion.
Victoria Cabrera-Shaarp
P310
Pubertal Induction in Males with Isolated Hypogonadotropic Hypogonadism using Long-Acting Intramuscular Testosterone Undecanoate 1g depot (Nebido)
Anjali Santhakumar
P298
Steroid regulation of gene and protein expression of osteopontin and αvβ3 integrin in ovine endometrium
Tina Tremaine
P309
A Case of Persistent Mullerian Duct Syndrome
Emma McCracken
P308
Effect of ethnicity on the clinical presentations of women with Polycystic Ovary Syndrome; a 20-year retrospective cohort study
Hamidreza Mani
P289
Maternal corticosterone regulates amino acid allocation to fetal growth in mice
Owen Vaughan
P294
Intrahepatic Cholestasis of Pregnancy Levels of Sulfated Progesterone Metabolites Downregulate Hepatic LXRα
Vanya Nikolova
P299
The effect of mTOR blockers on japanese quail ovarian granulosa cell functions
Attila Kadasi
P295
DNA methyltransferase (DNMT) 3a, 3b and 3L expression in fetal germ cells and its modulation
Thomas Chambers
P300
K<sub>ATP</sub> channels are involved in the tocolytic effect of ß<sub>2</sub> agonists in pregnant rat.
Norbert Lovasz
P306
Regulation of LH/CG receptor signaling in human endometrium and perturbations in recurrent pregnancy loss
Camilla West
P311
White Matter Changes on Magnetic Resonance Imaging in Klinefelter Syndrome
Deepa Beeharry
P312
Metformin Treatment of PCOS: St. George's Hospital Endocrine Unit Clinical Experience.
Hannah Walton
P291
Is diethylstilboestrol (DES) an endocrine disruptor in the developing human fetal testis? Effects of DES exposure using a xenograft approach.
RT Mitchell
P313
Myotonic dystrophy: A rare cause of primary hypogonadism
Alison Thorne
P303
IN VITRO EFFECT OF 4-NONYLPHENOL AND 17ß-ESTRADIOL ON BOVINE SPERMATOZOA
Jana Lukacova
P304
Effects of iron on the steroidogenesis of human adrenocarcinoma (NCl-H295R) cell line in vitro.
Zuzana Knazicka
P302
Effect of T-2 toxin and combination of T-2 toxin with resveratrol and MC2183 on ovarian cells of Japanese quails
Nora Maruniakova
P297
Tocopherol interacts with beta-mimetic effect in reproductive and respiratory tracts in the rat
Ágnes Hódi
P301
Possible role of fetuin-B in the preterm delivery in the rat
Eszter Ducza
P293
Pulsatile GnRH Signaling to ERK: Relevance of Pulse Duration and Frequency
Rebecca Perrett
P296
DISSECTING THE PROKINETICIN RECEPTOR DIMERIZATION INTERFACE: A ROLE IN KALLMANN SINDROME?
Silvia Sposini
P292
Perinatal origins of adult Leydig cells and function: role of developmental androgens
Karen Kilcoyne
P305
Gaining a better understanding of individual experiences of weight regulation in Polycystic Ovary Syndrome.
Gill Cooper
P307
Kisspeptin-54 administration stimulates LH pulsatility in women with Hypothalamic Amenorrhoea
Ali Abbara
P256
CORRELATION OF CLINICAL SMELL TEST AND MAGNETIC RESONANCE IMAGING OF OLFACTORY SYSTEM IN IDIOPATHIG HYPOGONADOTROPIC HYPOGONADISM
SUNIL KUMAR KOTA
P276
TSH-secreting pituitary adenoma identified in pregnancy: management of an unusual case
Jessica Triay
P260
Incidental pituitary haemorrhage is common in prolactin-secreting macroadenoma especially in women
Komil Sarwar
P250
Maternal vocalisation as an effective priming method for Oxytocin in young adults
Katie Daughters
P253
In vivo characterisation of skeletal muscle metabolism in growth hormone deficient adults using phosphorus-31 Magnetic Resonace Spectroscopy
Akash Sinha
P274
Hypopituitarism presenting with features of stiff person syndrome RN Mudaliar<sup>1</sup>, S Wilson<sup>1</sup>, SJ Howell<sup>1</sup>, S Shaunak<sup>2</sup>, K Kaushal<sup>1</sup><sup></sup> Departments of Endocrinology<sup>1</sup> and  Neurology<sup>2</sup>, Lancashire Teaching Hospitals NHS Foundation Trust, Sharoe Green Lane, Preston, Lancashire
RN Mudaliar
P285
Rapidly progressive pituitary carcinoma in a young female
Sumithra Giritharan
P266
Long-term results after treatment of craniopharyngioma- experience with 46 adult patients
Cristina Capatina
P282
Spontaneous Resolution of Pituitary Cushing’s
Malik Humayun
P271
AN UNUSUAL CAUSE OF TESTOSTERONE DEFICIENCY
CECIL EBOH
P267
Syndrome of Inappropriate antidiuretic hormone secretion and treatment with tolvaptan - a case series
Edward Jude
P268
Hyponatraemia assessment and outcomes in acute medically ill patients
Edward Jude
P261
OPHTALMOLOGICAL, ENDOCRINE, AND NEUROLOGICAL COMPLICATIONS IN GIANT MALE PROLACTINOMAS.
Farida Chentli
P277
A rising TSH in a patient with known TSHoma does not necessarily indicate recurrence
Dhruvkumar Laheru
P278
Unusual presentation of acromegaly and functioning pituitary gonadotrophinoma (FSHoma)
Shwe Zin Chit Pan
P275
Snake Bite and Hypopituitarism: Ignorance or incompetence?
Akshatha Taranath Kamath
P245
Transport features of pituitary folliculostellate cells and pregnancy
Helen Christian
P244
Secretory granule accumulation in anterior pituitary somatotrophs of TPC1 null mice
Helen Christian
P249
‘Invasion signature' revealed by the analysis of AIP positive and AIP mutation negative human pituitary adenomas
SAYKA BARRY
P262
Endocrine and Radiological Abnormalities in Empty Sella Syndrome
Sophie Westland
P283
A case of complex neurodevelopmental abnormality causing asymtomatic SIADH
Anjali Gondhalekar
P284
HYPOPITUITARISM WITH VISUAL FIELD LOSS IS NOT ALWAYS AN ADENOMA
Umar Farooq
P247
Polymersomes-mediated siRNA delivery for states of hormone excess
Georgia Bakirtzi
P246
Chronic glucocorticoid exposure causes de-novo methylation of genes key to the regulation of the hypothalamic-pituitary-adrenal (HPA) axis
Georgia Bakirtzi
P254
Creation of a locus-specific database (LSDB) for AIP mutations
Fauzia Begum
P279
Pituitary Apoplexy and Aortic Dissection RN Mudaliar<sup>1</sup>, A Golash<sup>2</sup>, K Kaushal<sup>1</sup>, SJ Howell<sup>1</sup>Departments of Endocrinology<sup>1</sup> and  Neurosurgery<sup>2</sup>, Lancashire Teaching Hospitals NHS Foundation Trust, Sharoe Green Lane, Preston, Lancashire
RN MUDALIAR
P272
Rare case of round blue cell pituitary tumour with probable hypothalamic involvement
Sviatlana Zhyzhneuskaya
P257
Endocrine remission of Cushing's disease after endoscopic trans-sphenoidal surgery: Retrospective review of a single centre experience
Devon Kennard
P280
Isolated central hypoadrenalism as the sole manifestation of presumed neurosarcoidosis  
Sviatlana Zhyzhneuskaya
P263
<sup>11</sup>C-Methionine PET-CT co-registered with volume MRI identifies residual functioning tumour in acromegaly
Olympia Koulouri
P286
Aggressive meningioma in a female patient with uncontrolled congenital adrenal hyperplasia
Triona O'Shea
P258
Prevalence of familial isolated pituitary adenomas (FIPA)
M. Herincs
P269
Inside acromegaly: a pilot study for recruiting focus groups using social media
Oluwasomidotun Idowu
P248
Transcriptional regulation of C-type natriuretic peptide (CNP/Nppc) and its receptor guanylyl cyclase-B (GC-B/Npr2) in gonadotroph and somatolactotroph cell lines
Samantha Mirczuk
P264
A retrospective cohort study of patients with hyperprolactinaemia
Alexandra Banner
P265
Examining the distribution of abdominal fat in Growth hormone deficiency using Magnetic Resonance Imaging
Akash Sinha
P252
Craniopharyngiomas and Wnt signalling pathways
Veronica Preda
P281
Etiology and outcome of hyponatremia due to pituitary insufficiency in a tertiary endocrine center
Raluca-Alexandra Trifanescu
P270
Pituitary Apoplexy – A case series
IOANNIS DIMITROPOULOS
P255
High Prevalence of Pituitary Dysfunction following Blast Traumatic Brain Injury and associated diffusion tensor imaging findings: Results from the United Kingdom Blast Injury Outcome Study of Armed Forces Personnel (BIOSAP)
Claire Feeney
P251
Altitude acclimatization: Plasma AVP response and physiological changes
Meenakshi Sachidhanandam
P273
Pituitary abscess - a rare cause of pituitary mass lesion
Srinivasa Kummaraganti
P287
Finally we know! ‘It comes from your pituitary'.
Nazia Rashid
P259
Short-term (3 months) compared to long-term response to somatostatin analogues in acromegaly
Monica Livia Gheorghiu
P93
TUBEROUS SCLEROSIS: AN UNCOMMON CAUSE OF HYPERPROLACTINEMIA
SUNIL KUMAR KOTA
P116
PELVIC PAIN IN A TYPE 2 DIABETES PATIENT
SUNIL KUMAR KOTA
P127
A challenging case of recurrent disabling severe hypoglycemic episodes
Kirthika Jeyaraman
P66
A Very Interesting Presentation: VIP co-secretion by a phaeochromocytoma
Jessica Triay
P59
Outcomes of transsphenoidal surgery (TSS) for acromegaly
Irfanulla Baig
P117
Clinical Practice Hyperaldosteronism- A misleading adrenal tumorP Verlekar, A Norris, J Chong, Department of Diabetes & Endocrine, RHCH, Romsey road, Winchester SO22 5DG
Pankaj Verlekar
P79
Tertiary hyperparathyroidism due to chronic severe vitamin D deficiency in ethnic minority patients - a case series
Mahmud Ahmed
P118
Bilateral adrenal calcification caused by a previous Streptococus mitis septicaemia
Mohamed Ahmed
P119
A question of growth hormone deficiency or not
Sondra Gorick
P80
Hypercalcaemia due to simultaneous presentation of primary hyperparathyroidism and metastatic oesophageal cancer
Hiang Leng Tan
P94
Acute diabetic autonomic neuropathy as phaeochromocytoma mimic.
Deirdre Maguire
P120
Ectopic ACTH syndrome as a presenting symptom of bronchogenic carcinoma
Safwaan Adam
P104
Ectopic thyroid tissue presenting as metastatic follicular cancer
Syed H Ahmed
P105
A Peculiar Case of a Dog Bite
Vilashini Arul Devah
P121
Secondary diabetes due to phaeochromocytoma
Jayadave Shakher
P106
Management of Diabetic ketoacidosis In a District General Hospital:  A Three Years Retrospective Audit.
Mohamed Ahmed
P70
Normal plasma and urine catecholamines in a patient with symptoms and radiological findings of a phaeochromocytoma cured by laparoscopic adrenalectomy
Yasir Mohamed Elhassan
P60
How do medical students and doctors learn clinical endocrinology?
Mehul Patel
P71
Bariatric surgery in a patient with melanocortin 4 receptor mutation
Hanaa Elkhenini
P81
"There is nothing more deceptive than an obvious fact", Sherlock Holmes: A case report of thyroid sarcoidosis
Claudia Escalante
P122
Absent thyroid with growth hormone deficiency
Flaminia Bruno
P95
Hypervitaminosis D, an uncommon reality!
ZH Mansuri
P72
Tolvaptan treatment in hyponatraemia due to chronic heart failure
Jayadave Shakher
P130
Radioactive Iodine induced Hyperparathyroidism
VANI SHANKARAN
P96
Simultaneous presentation of Graves' Thyrotoxicosis and Addison's disease presenting as incipient Adrenal crisis
Murali Ganguri
P97
Severe refractory non-islet cell tumour hypoglycaemia due to metastatic colorectal carcinoma.
Murali Ganguri
P98
Unusual presentation of central pontine myelinolysis
Jayadave Shakher
P82
A case of severe hypoaldosteronism following unilateral adrenalectomy for Conn's Syndrome
Alistair Connell
P99
SIADH and Bilateral Adrenal Infarction in a Patient with the Antiphospholipid Syndrome.
Winston WS Fung
P61
An unusual cause of Cushing’s syndrome with secondary adrenal insufficiency
Amalia Iliopoulou
P83
SDHB mutation and a large asymptomatic paraganglioma in a young woman: the importance of taking a good family history
Stuart Foster
P123
Bone Mineral Density (BMD) improvement in clinical practice in patients with osteoporosis on current NICE recommended treatments: an audit
Rachel Reed
P62
Management of Intercurrent Illness in Adrenal Insufficiency
Rachel McLatchie
P67
A Single Pathology Specialty Service for Hyperthyroid Patients improves care and outcomes compared to general endocrine clinics – results and implications of an audit: re-audit cycle of clinical outcomes for differing hyperthyroid care models.
Jean Munday
P107
Unusual presentations of adrenocortical tumours
Omar Mustafa
P63
A case of Hashimoto's thyroiditis induced coagulopathy
Anthony Lewis
P84
The challenges of a dopamine secreting paraganglioma
Anthony Lewis
P73
Hypercalcaemia Secondary to Colecalcifrol Administration in Undiagnosed Sarcoidosis.
Naveen Aggarwal
P85
LITHIUM-INDUCED HYPERPARATHYROIDISM SUCCESSFULLY TREATED WITH CINACALCET: 2 CASE REPORTS
Mohammad Hassan Bholah
P86
Recurrence of a brown tumour in a patient with secondary hyperparathyroidism due to severe vitamin D deficiency
Marie-France Kong
P64
Conn’s syndrome with normal plasma renin aldosterone ratio
Myat Thida
P124
Accelerated renal impairment in a patient with type 2 diabetes with an inadequately investigated incidental adrenal adenoma
Marie-France Kong
P100
Incidental papillary thyroid carcinoma with primary hyperparathyroidism: two cases
Khyatisha Seejore
P134
Diarrhoea and an adrenal incidentaloma
Samuel Bruno
P131
A Case of Phaeochromocytoma presenting as incidentloma
Bashir K El-Mahmoudi
P128
"Gastroparesis” in a patient with uncontrolled diabetes - NOT always Autonomic Neuropathy!
Manikya Kuriti
P132
Propylthiouracil Induced Severe Agranulocytosis!
Manikya Kuriti
P129
Audit on Continuous Subcutaneous Insulin Infusion (CSII) in Colchester General Hospital
Nyi Htwe
P108
An audit of the diagnosis and management of hypogonadism in adult men.
P W James Russell
P87
An Uncommon Presentation of a Common Endocrine Condition
Saurabh Bansal
P57
Initiation and maintenance of mitotane as adjuvant therapy for adrenocortical cancer: a single centre experience
Benjamin Whitelaw
P88
Rare case of Pheochromocytoma presenting in pregnancy
Jehangir Abbas
P101
Hypercalcaemia as First Presentation of Sarcoidosis.
Naveen Aggarwal
P89
Non Islet Cell Tumour Hypoglycaemia resistant to medical treatment.
Mohammad Rahman
P74
Spironolactone interference in the immunoassay of androstenedione in a patient with a cortisol-secreting adrenal adenoma
Rachel K Crowley
P109
PITUITARY TUBERCULOSIS
Santhosh HS
P68
Novel use of subcutaneous octreotide via an insulin pump for Postural orthostatic Tachycardia Syndrome (PoTS)
Muhammad Khan
P90
An unusual case of pancreatitis: a case report
Victoria Goodall
P110
The difficulties in diagnosing and treating a phaeochromocytoma in a patient with multiple co-morbidities.
Dearbhla McKenna
P75
An unusual case of confusion and hyponatraemia
Jenni Harrison
P91
A painful neck in a young well looking man presenting to A
Chioma Izzi-Engbeaya
P111
Adrenal Incidentalomas: Who requires further testing?
Aikaterini Theodoraki
P58
De Novo HNF1-Beta Mutation as a Cause For Chronic Treatment Resistant Hypomagnesaemia
Craig Stiles
P112
Growth Hormone therapy in adults with Prader-Willi Syndrome (PWS)
Lisa Wynn
P69
Management of primary hyperparathyroidism during pregnancy: presentation of six cases and the lessons learnt.
Katherine McCullough
P92
Life threatening airway obstruction secondary to a large probable parathyroid cyst.
Katherine McCullough
P113
Primary Hyperparathyroidism in Pregnancy- A Conservative Approach
HJ Wallace
P76
Hypernatraemia with reset osmostat associated with secondary hypogonadism
Yasir Mohamed Elhassan
P125
Nephrogenic diabetes insipidus caused by lithium toxicity.
Christopher Kyriacou
P65
Peri-operative alpha-blockade: Efficacy of intravenous Phenoxybenzamine versus oral Phenoxybenzamine in patients with phaeochromocytoma and paraganglioma
Shazia Hussain
P135
MULTIPLE AUTOIMMUNE DISEASES IN NIGERIA: IS IT RARE?  
Olubukola Ojo
P114
Audit of the Management of Primary Hyperparathyroidism at Watford General Hospital
Matthew Allum
P77
A Case of Dry Beriberi Following Bariatric Surgery
Alice Verran
P133
Rare Onset Of Polyendocrinopathies In A Pediatric Patient
Nithi Fernandes
P78
Giant parathyroid adenoma extending into the mediastinum: a case report
Mimi Chen
P115
Potential role of antituberculosis treatment as cause of severe hypocalcaemia immediately following total thyroidectomy
ChenchiReddy Kankara
P102
Tumours metastatic to the pituitary gland presenting with atypical symptoms
Maneesh Udiawar
P126
A case of primary hypoadrenalism secondary to amyloidosis.
John Watkins
P103
Acute adrenal insufficiency due to bilateral adrenal haemorrhagic infarction associated with sepsis secondary to an open fracture of the ankle
Ben Brookes
P357
VITAMIN D STATUS IN AUTOIMMUNE HYPOTHYROIDISM
SUNIL KUMAR KOTA
P385
Audit of use of radioactive iodine (RAI) in the treatment of thyrotoxicosis at the Bristol Royal Infirmary (2008 - 2009)
John Jitan
P353
Low frequency of pendrin autoantibodies detected using a radioligand binding assay in patients with autoimmune thyroid disease
Elizabeth Kemp
P383
Case report: When measured free T<sub>4</sub> and free T<sub>3</sub> may be misleading. Interference with free thyroid hormones measurements on Roche® and Siemens® platforms
Krzysztof Lewandowski
P386
Successful pregnancy outcomes with thyroxine treatment in euthyroid women with positive thyroid autoantibodies and recurrent miscarriage
Tolulope Shonibare
P388
Myxedema Coma-An uncommon presentation of a common thyroid problem
Atif Munir
P387
Carbimazole induced cholestatic hepatitis
Hamza Khan
P371
Factors affecting choice of definitive therapy in patients with relapsed thyrotoxicosis
Hend Moussa
P372
Levothyroxine absorption testing: a 5-day (usual dose) test as an alternative to the 1-day (1000mcg) test
P Vas
P376
Thyroid dermopathy - an extreme variant
Kalpita Majumdar
P366
A Rapidly Enlarging Neck Lump and Horner's Sign: Lessons from a Novel Case
Rajeev Parameswaran
P373
Four cases of thyroid carcinoma presenting in childhood: Fifteen years experience in a national tertiary referral centre.
Ian Wallace
P367
The Presence of Thyroid Peroxidase Antibodies in Graves disease is Predictive of Disease duration and Relapse rates
furat wahab
P377
Too low, too high. Is it the Roux-en-Y? Fluctuating thyroid function following obesity surgery.
James Crane
P378
NOT ALL RAISED T4 NEEDED TREATMENT!
Tauseef Kapadi
P360
Homozygous Resistance to Thyroid Hormone: Can Cardiac Complications be Prevented?
Carla Moran
P361
Factors predicting the development of hypothyroidism after radioiodine treatment
Jeanny Varghese
P374
Acute transient thyrotoxicosis following intensity-modulated radiotherapy to the neck. 
James Ahlquist
P354
Interferon induced Thyrotoxicosis
Veneranda Lorelei Salazar
P375
Evaluation of fine needle aspiration and ultrasound in diagnostic assessment of thyroid nodules.
SV Sagi
P358
Prevalence of anti-thyroglobulin antibodies, their prognostic significance and impact on patient care in a cohort of patients with differentiated thyroid cancer
Sam O'Toole
P368
Managing graves disease: Management involving endocrine nurse led service. Experience from DGH.
Aftab Aziz
P356
Thyroid Incidentaloma Incidence and Malignant Prevalence in F-18-FDG-PET/CT Imaging
Rebecca Gorrigan
P379
A case of metastatic papillary thyroid carcinoma presenting with pleural, pulmonary and bone metastases
Sathish Babu Parthasarathy
P352
Local regulation of T3 availability in susceptibility to osteoarthritis
JA Waung
P362
Does closer monitoring of thyroid function post radioiodine reduce the severity of hypothyroidism when first detected?
Myat Thida
P369
Thyroid Nodules, FNA Cytology and Thyroid Cancer in Malta
Mark Gruppetta
P363
Interferon Induced Thyroid Dysfunction: A Case Series
Devesh Sennik
P380
Raised TSH - a diagnostic conundrum!
Misbah Mohammad
P364
Clinical performance of fine-needle aspiration biopsy of thyroid nodules in a tertiary referral centre
Nigel Glynn
P381
Bilateral Thyroid Cysts- an association not to forget?
Tristan Richardson
P370
False positive Pentagastrin Stimulation test in a family with Medullary Thyroid Cancer
Laurence Fulford
P365
The challenge of managing refractory amiodarone-induced Graves disease in Resistance to Thyroid Hormone
Carla Moran
P382
An unusual association with autoimmune hypothyroidism
Louise Overend
P384
Management of Thyrotoxic Crisis in a Brittle Asthmatic
George Barrett
P359
Factors prompting thyroid function testing in hospitalised patients with thyroid dysfunction: Analysis of a large hospital database
Barbara Torlinska
P355
Levothyroxine therapy affects Cerebral Blood Flow and Fatigue in Subclinical Hypothyroidism
Nasar Aslam
P47
HYPONATREMIA IN PATIENTS WITH FRACTURED NECK OF FEMUR: SHORT AND MEDIUM TERM OUTCOMES
Thenmalar Vadiveloo
P40
HPLC Analysis on Separation of BSA from Dilute Solution
Goutam Mukhopadhyay
P38
Development of an Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) Method for Measurement of Urine Iodine & Assessment of Iodine Status in Subclinical Hypothyroidism
Marian Ludgate
P42
Glycosylated Linkers to generate long-acting growth hormone tandems
Pippa Cawley
P51
Liquorice induced hypertension and hypokalaemia
Hamza Khan
P52
Calcification of basal ganglia in chronic hypoparathyroidism
Hamza Khan
P39
Cross-reactivity of ten recombinant insulin preparations in the Abbott Architect Insulin immunoassay
Catriona Clarke
P41
MSIA-SRM assay for parathyroid hormone and vitamin D binding protein: Correlation with clinical immunoassay methods and application to clinical samples.
Lewis Couchman
P46
Service review and demand management following clinical audit of urine free cortisol requesting at Barts Health NHS Trust.
Fiona Riddoch
P44
Danazol cross-reacts in the Roche E170 Testosterone assay
Fiona Riddoch
P49
An unusual case of chronic liquorice ingestion presenting as hypokalemic paralysis.
Pallavi Hegde
P35
A rapid and sensitive LC-MS/MS assay for the routine analysis of estradiol and estrone
Laura Owen
P50
Role of urinary dopamine in investigation of phaeochromocytoma/paraganglioma
Christopher Smith
P56
Audit of inpatient management of hyponatraemia
Bhavin Patel
P36
The Search for 3-Epi-25-Hydroxy Vitamin D
Jonathan C .Y. Tang
P48
A comparison of serum chromogranin A measurement with 24h urine and serum 5-hydroxyindole acetic acid (5-HIAA) measurement in patients with NETs
Phillip Monaghan
P45
Persistent hyperparathyroidism following parathyroidectomy - Can routine Vitamin D replacement prior to surgery alter post-operative secondary hyperparathyroidism?
Natalie Chand
P37
Plasma metanephrine analysis by Online Solid Phase Extraction LC-MS/MS
Joanne Adaway
P53
A review of causes of hypomagnesaemia in hospital patients and its management.
Jana Bujanova
P55
Impact of hyponatraemia in critically ill patients
Jayadave Shakher
P54
An audit on management of hyponatraemia in hospitalised patients
VMR Katreddy
P43
High pulmonary artery pressure is associated with BNP and NT-proBNP in lowlanders acclimatising to high altitude
A Mellor
P337
Osteoporosis prophylaxis in medical patients taking corticosteroids
Thomas Carter
P346
ACTH independent bilateral  macronodular adrenal hyperplasia presenting as  Subclinical Cushing's Syndrome
Myat Thida
P347
A case of hypocalcaemia in ectopic ACTH production
Myat Thida
P331
Quality of life relates to glucocorticoid treatment regimen, adiposity and insulin resistance in adults with congenital adrenal hyperplasia: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)
Thang S Han
P325
Dual role of TTC5 cofactor in GR mediated gene expression
Malihah Sadeq
P323
Mechanisms of estrogen receptor transcription in breast cancer
Jason Carroll
P324
CONTINUOUS MEASUREMENT OF FREE CORTISOL PROFILES
Ragini C Bhake
P342
An online survey on awareness regarding steroid therapy and sick day rules.
Surya Rajeev
P339
Spot urine cortisol: creatinine ratio – a useful screening test for patients with Cushing’s syndrome
Thomas Paul
P348
Bilateral Enlarging Adrenal Masses: When can we wait in indeterminate lesions?
Prashanth Vas
P336
Reversal of dilated cardiomyopathy in a patient with Cushing's syndrome after a successful adrenalectomy.
Nadeem Abbas
P316
Validation of CYP11B1 and CYP11B2 Regulation by microRNA-24
Louise Diver
P315
11βHSD1 deficiency increases susceptibility to liver fibrosis by activating hepatic stellate cells
Xiantong Zou
P326
Identification of a Novel CYP11B1 Isoform in Human Adrenocortical Cells
Samantha Alvarez-Madrazo
P329
P450 side-chain cleavage enzyme autoantibodies in canine Addison's disease
Alisdair Boag
P332
Truncal fat distribution is associated with enhanced glucocorticoid excretion, increased 5α-reductase activity and higher insulin resistance independent of body mass index in women with polycystic ovary syndrome
Michael O'Reilly
P343
Antiphospholipid Antibody (APLA) Syndrome: Adrenal Insufficiency
Sampath Satish Kumar
P318
Novel loci for familial autoimmune Addison's disease detected by linkage analysis
Anna L Mitchell
P340
Successful Use Of Subcutaneous Infusion of Cortisol In An Adult Case Of Congentital Adrenal Hyperplasia.
Yahya Mahgoub
P333
Revival of adrenal function in established autoimmune Addison's disease
Earn H Gan
P327
The role of anti-ACTH<sub>1-24 </sub>antibodies in synacthen-related adverse events
Earn H Gan
P344
Feature of acute mineralocorticoid excess from ACTH secreting Bronchial Tumour
Mansour Seidahmad
P345
Cranial diabetes insipidus in a patient with previously cured pregnancy associated adrenal Cushing's syndrome.
FJS Haddadin
P349
Hypokalaemia - A Happy Outcome
mithun bhartia
P319
Identification of a duplicated P450 side-chain cleavage enzyme (zCyp11a2) defines initiation and maintenance of steroidogenesis in zebrafish
Silvia Parajes
P320
Glucocorticoids Enhance Insulin Sensitivity in Human Hepatocytes
Maryam Nasiri
P322
Steroid profile response to Angiotensin II and ACTH in normal volunteer under high and low salt conditions
Frances McManus
P317
Molecular mechanisms underlying the anti-inflammatory properties of 5α-tetrahydrocorticosterone (5αTHB)
Annalisa Gastaldello
P328
<sup>19</sup>F-Magnetic Resonance Spectroscopy as a tool to quantify 11β‑hydroxysteroid dehydrogenase activity in vivo.
Gregorio Naredo-Gonzalez
P321
The zebrafish ferredoxin ortholog Fdx1b is essential for the redox regulation of interrenal steroidogenesis in larvae and adult fish.
Aliesha Griffin
P351
An interesting case of adrenal adenoma
Shankar Dhandapani
P338
A 'Heavy' price of beauty therapy.
Nazia Rashid
P335
Gonadotrophic response to operational deployment in Afghanistan
NE Hill
P330
Quantitative analysis of canrenone in plasma by triple quadrupole mass spectrometry
Natalie Homer
P334
RANGE OF URINARY STEROID METABOLITE RATIOS IN CHILDREN UNDERGOING INVESTIGATION FOR SUSPECTED DISORDER OF STEROID SYNTHESIS
Angela Lucas-Herald
P341
An audit of Adrenal venous sampling at University College Hospital, London
Ali Rathore
Mon 18 11:00
S1.1
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
Iron homeostasis: who are the major players?
La Jolla, USA
Mon 18 11:30
S1.2
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
The iron regulatory hormone hepcidin
Mon 18 12:00
S1.3
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
'The Celtic disease' - haemochromatosis: a disease of iron overload
Innsbruck, Austria
Mon 18 11:00
S2.1
Symposium 2: Hormones Maketh Man
Anti-müllerian hormone - a Sertoli cell hormone that can be used as a predictor of male hypogonadism
Buenos Aires, Argentina
Mon 18 11:30
S2.2
Symposium 2: Hormones Maketh Man
The role of the Sertoli cell in driving 'maleness'
Geneva, Switzerland
Mon 18 12:00
S2.3
Symposium 2: Hormones Maketh Man
Androgens and male fertility - a long way from the black box theory
Mon 18 11:00
S3.1
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Epigenome-wide association studies for common human diseases
Mon 18 11:30
S3.2
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Nutritional programming of epigenetics in metabolic syndrome
Manchester, UK
Mon 18 12:00
S3.3
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Epigenetic differences associated with prenatal exposure to famine in humans
Columbia, USA
Mon 18 12:30
Otsuka satellite symposium:

The hyponatraemic brain and bone: current and future treatment targets

QUEEN'S SUITE A (lunch available in QS foyer)
Chair: R Eastell (Sheffield)
J Verbalis (Georgetown, WA, USA)
Mon 18 12:30
LUNCH
HALL H
Mon 18 13:45
S4.1
Symposium 4: New Bone Biology - Is there life after RANK ligand?
New bone biology and Cathepsin K inhibitors
Mon 18 14:15
S4.2
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Inhibition of sclerostin in the treatment of osteoporosis
Leiden, The Netherlands
Mon 18 14:45
S4.3
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Parathyroid hormone related peptide as a potential treatment for osteoporosis
Madrid, Spain
Mon 18 15:15
S4.4
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Organic nitrates for the treatment of postmenopausal osteoporosis
Toronto, Canada
Mon 18 13:45
OC1.1
Oral Communications 1: Young Endocrinologists's Prize Session
TNFα directly regulates in vivo corticosteroid metabolism in inflammatory arthritis
Mon 18 14:00
OC1.2
Oral Communications 1: Young Endocrinologists's Prize Session
Macrophage-specific 11β-hydroxysteroid dehydrogenase type 1 deficiency promotes angiogenesis but impairs resolution of K/BxN serum induced arthritis
Mon 18 14:15
OC1.3
Oral Communications 1: Young Endocrinologists's Prize Session
11β-HSD1KO mice are protected from glucocorticoid dependent age-associated muscle atrophy
Mon 18 14:30
OC1.4
Oral Communications 1: Young Endocrinologists's Prize Session
A Serum MicroRNA Profile Potentially Associated with Glucocorticoid Mediated Insulin Resistance
Mon 18 14:45
OC1.5
Oral Communications 1: Young Endocrinologists's Prize Session
Inhibition of 5α-reductase type 1 with dutasteride impairs insulin sensitivity
Mon 18 15:00
OC1.6
Oral Communications 1: Young Endocrinologists's Prize Session
Improving the Vitamin D status of Vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle
Mon 18 15:15
OC1.7
Oral Communications 1: Young Endocrinologists's Prize Session
Autosomal dominant hypocalcemia type 2 is caused by germline GNA11 gain-of-function mutations
Mon 18 15:30
OC1.8
Oral Communications 1: Young Endocrinologists's Prize Session
Kisspeptin advances ovulation in healthy women
Mon 18 13:45
APW1.1
Applied Physiology Workshop
Modelling neuroendocrine systems
Mon 18 14:15
APW1.2
Applied Physiology Workshop
Distinguishing normal, depressive and PTSD cortisol dynamics in humans through mathematical modelling
Santa Barbara, USA
Mon 18 14:45
APW1.3
Applied Physiology Workshop
Analysis and visualisation of biological networks
Mon 18 15:15
APW1.4
Applied Physiology Workshop
Modelling the circulating renin-angiotensin system and its efefcts on blood pressure
Poitiers, France
Mon 18 15:45
TEA & COFFEE
HALL H
Mon 18 16:15
CMW1.1
Clinical Management Workshop 1: Management controversies in parathyroid disease
Hyperparathyroidism in MEN1
Florence, Italy
Mon 18 16:45
CMW1.2
Clinical Management Workshop 1: Management controversies in parathyroid disease
Parathyroid hormone, vitamin D and chronic kidney disease
Mon 18 17:15
CMW1.3
Clinical Management Workshop 1: Management controversies in parathyroid disease
'Mild hyperparathyroidism' - what determines clinical outcome?
Mon 18 17:45
CMW1.4
Clinical Management Workshop 1: Management controversies in parathyroid disease
Medical management of parathyroid disease
Mon 18 16:15
EW1.1
Education Workshop 1: Teaching and Learning in Endocrinology
Undergraduate research participation: going beyond 'students as producers'
Mon 18 16:45
EW1.2
Education Workshop 1: Teaching and Learning in Endocrinology
Clinical skills delivery
Mon 18 17:15
EW1.3
Education Workshop 1: Teaching and Learning in Endocrinology
Recommended standards for undergraduate medical education
Mon 18 17:45
EW1.4
Education Workshop 1: Teaching and Learning in Endocrinology
Postgraduate training in endocrinolgoy and diabetes - developing the curriculum and assessments
Mon 18 16:15
S5.1
Symposium 5: Sex in the brain
Foetal testosterone in mind
Mon 18 16:45
S5.2
Symposium 5: Sex in the brain
Importance of genomic imprinting in the evolution and development of the maternal brain
Mon 18 17:15
S5.3
Symposium 5: Sex in the brain
Neuronal circuits underlying sex specific social behaviour
Cambridge, USA
Mon 18 17:45
S5.4
Symposium 5: Sex in the brain
Hormone-dependent chromatin modifications regulating sexually differentiated animal behaviour
New York, USA
Mon 18 16:15
OC2.1
Oral Communications 2: Steroids and thyroid
Loss-of-Function Mutations in IGSF1 Cause a Novel, X-Linked Syndrome of Central Hypothyroidism and Testicular Enlargement
Mon 18 16:30
OC2.2
Oral Communications 2: Steroids and thyroid
Abnormal cardiac bio-energetics in subclinical hypothyroidism; cardiac magnetic resonance spectroscopic study
Mon 18 16:45
OC2.3
Oral Communications 2: Steroids and thyroid
A bi-transgenic murine model of PTTG and PBF overexpression in the thyroid gland
Mon 18 17:00
OC2.4
Oral Communications 2: Steroids and thyroid
THRA or DIO2 mutations are not a common cause of high bone mass in humans
Mon 18 17:15
OC2.5
Oral Communications 2: Steroids and thyroid
A mutation in thioredoxin reductase 2 (TXNRD2) is associated with a predominantly adrenal phenotype in humans
Mon 18 17:30
OC2.6
Oral Communications 2: Steroids and thyroid
An N-ethyl-N-nitrosourea induced Corticotrophin releasing hormone (Crh) promoter mutation provides a mouse model of Cushing’s syndrome
Mon 18 17:45
OC2.7
Oral Communications 2: Steroids and thyroid
11β-hydroxysteroid dehydrogenase type 1: A role in skin wound healing
Mon 18 18:00
OC2.8
Oral Communications 2: Steroids and thyroid
When math meets biology: systems approach to drug resistance analysis
Mon 18 18:00
YEP1.2
Young Endocrinologists Prize Lectures
Pituitary development: the answer, is blowing in the Wnt
Mon 18 18:00
YEP1.1
Young Endocrinologists Prize Lectures
Clinical and pre-clinical studies of neuroendocrine tumours (NETs) in Multiple Endocrine Neoplasia type 1 (MEN1), and evaluation of MEN1 gene replacement therapy for MEN1-associated NETs.
Mon 18 19:15
Welcome Reception
HALL H
Mon 18 20:00
Young Endocrinologists Quiz
HALL D
Tue 19 07:00
BREAKFAST
QUEEN'S SUITE FOYER
Tue 19
MTE2
Meet the Expert 2
Diabetes metellitus, endocrinology and the impact of GP commissioning
Tue 19
MTE3
Meet the Expert 3
Investigation of patients with suspected mineralocorticoid hypertension
Tue 19
MTE1
Meet the Expert 1
Turner Syndrome / pregnancy / cardiac risk
Tue 19 08:15
S6.1
Symposium 6: Making the glucocorticoid clock run smoothly
Monitoring glucocorticoid signalling and circadian clock function with transgenic zebrafish reporter lines
Karlsruhe, Germany
Tue 19 08:45
S6.2
Symposium 6: Making the glucocorticoid clock run smoothly
Molecular dynamics of ultradian glucocorticoid receptor action
Tue 19 09:15
S6.3
Symposium 6: Making the glucocorticoid clock run smoothly
Diurnal cortisol delivery: a novel tool for adrenal insufficiency
Tue 19 09:45
S6.4
Symposium 6: Making the glucocorticoid clock run smoothly
Retraining the HPA axis: how to cure adrenal insufficiency
Newcastle, UK
Tue 19 08:15
OC3.1
Oral Communications 3: Reproduction, growth and development
Identification of very early sorting endosomes that spatially program gonadotrophin hormone receptor signalling
Tue 19 08:30
OC3.2
Oral Communications 3: Reproduction, growth and development
Heterodimerisation of gonadotrophin hormone receptors modifies the LH-induced calcium signalling profile
Tue 19 08:45
OC3.3
Oral Communications 3: Reproduction, growth and development
Regulation of G protein-coupling specificity via cis and trans activation of the luteinising hormone/chorionic gonadotrophin receptor (LHCGR)
London, UK
Tue 19 09:00
OC3.4
Oral Communications 3: Reproduction, growth and development
Characterising changes in the in vivo male rodent brain using Magnetic Resonance Spectroscopy
Tue 19 09:15
OC3.5
Oral Communications 3: Reproduction, growth and development
Effects of in utero exposure to acetaminophen (paracetamol) on steroidogenesis by the rat and human fetal testis
Tue 19 09:30
OC3.6
Oral Communications 3: Reproduction, growth and development
Follistatin-Like 3 (FSTL3), a transforming growth factor β (TGFβ) ligand inhibitor, is essential for placental development in mice.
Tue 19 09:45
OC3.7
Oral Communications 3: Reproduction, growth and development
Disruption of Mesenchymal Glucocorticoid Signaling Attenuates Embryonic Lung Development and Results in Post Natal Lethality in Mice
Tue 19 10:00
OC3.8
Oral Communications 3: Reproduction, growth and development
Adiponectin induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages
Tue 19 08:15
CMW2.1
Clinical Management Workshop 2: How Do I Do It?
How do I manage testosterone replacement after prostate cancer therapy?
Tue 19 08:35
CMW2.2
Clinical Management Workshop 2: How Do I Do It?
How do I investigate and manage hypomagnesaemia?
Birmingham, UK
Tue 19 08:55
CMW2.3
Clinical Management Workshop 2: How Do I Do It?
How do I monitor and follow up transgender patients using hormonal therapies?
Tue 19 09:15
CMW2.4
Clinical Management Workshop 2: How Do I Do It?
How do I manage the pregnant patient with a prolactinoma?
Tue 19 09:35
CMW2.5
Clinical Management Workshop 2: How Do I Do It?
How and when do I induce puberty in males?
Tue 19 09:55
CMW2.6
Clinical Management Workshop 2: How Do I Do It?
How do I - and how should I - induce puberty in females?
Tue 19 10:15
TEA & COFFEE
HALL H
Tue 19
PL1
SfE Dale Medal Lecture
Nuclear receptors and AMPK: can exercise mimetics cure diabetes?
La Jolla, USA
Tue 19
PL2
SfE Hoffenberg International Medal Lecture
Multiple applications of intracrinology in clinical medicine
Quebec, Canada
Tue 19 12:00
LUNCH & POSTER VIEWING
HALL H
Tue 19
Ipsen satellite symposium
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the PRIMARYS trial
Tue 19
Ipsen satellite symposium
Tumour response to presurgical lanreotide Autogel therapy in the ACROPAT trial
Tue 19
Ipsen satellite symposium
Stabilising tumour growth in patients with NETs
Tue 19 14:00
OC4.1
Oral Communications 4: Obesity, metabolism and bone
Glucocorticoid receptor deficiency in cardiomyocytes causes pathological cardiac remodelling in mice.
Tue 19 14:15
OC4.2
Oral Communications 4: Obesity, metabolism and bone
11β-HSD1 Knockout Mice are Protected from the Adverse Metabolic Effects of Exogenous Glucocorticoid Excess
Tue 19 14:45
OC4.4
Oral Communications 4: Obesity, metabolism and bone
Cholestatic pregnancy programmes metabolic disease in the offspring
Tue 19 14:45
OC4.3
Oral Communications 4: Obesity, metabolism and bone
Adult offspring of undernourished sheep exhibit epigenetic alterations in HPA axis glucocorticoid receptor
Tue 19 15:00
OC4.5
Oral Communications 4: Obesity, metabolism and bone
Energy intake following infusion of glucagon and GLP-1: a double-blind crossover study
Tue 19 15:15
OC4.6
Oral Communications 4: Obesity, metabolism and bone
Transgenic disruption of 5alpha-reductase1 increases susceptibility to liver fibrosis
Tue 19 15:30
OC4.7
Oral Communications 4: Obesity, metabolism and bone
Familial Hypocalciuric Hypercalcaemia Type 3 (FHH3) is Caused by Mutations in Adaptor Protein 2 Sigma 1 (AP2S1)
Tue 19 15:45
OC4.8
Oral Communications 4: Obesity, metabolism and bone
Peptide YY regulates bone mineral content and strength
Tue 19 14:00
S7.1
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Physiologically distinct roles for thyroid hormone receptor isoforms
Tue 19 14:30
S7.2
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Human thyroid hormone receptor alpha mutations - novel syndrome emerges
Tue 19 15:00
S7.3
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Human thyroid hormone receptor beta mutations - syndrome of resistance to thyroid hormone
Milan, Italy
Tue 19 15:30
S7.4
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Nuclear coregulators confer the actions of mutant thyroid hormone receptor alpha and beta
Bethesda, USA
Tue 19 14:00
YE1.1
YE Symposium: Maintaining your endocrine career despite what life throws at you
Maintaining an active basic research career whilst juggling an academic and personal life
Tue 19 14:15
YE1.2
YE Symposium: Maintaining your endocrine career despite what life throws at you
Juggling a clinical workload: and academic research
Dundee, United Kingdom
Tue 19 14:30
YE1.3
YE Symposium: Maintaining your endocrine career despite what life throws at you
Getting useful research results from routine NHS activity
Tue 19 14:45
YE1.4
YE Symposium: Maintaining your endocrine career despite what life throws at you
Non-traditional career paths towards an acedemic career
Tue 19 15:00
YE1.5
YE Symposium: Maintaining your endocrine career despite what life throws at you
Re-establishing your research profile after a career break (academic perspective)
Tue 19 15:15
YE1.6
YE Symposium: Maintaining your endocrine career despite what life throws at you
Putting your best foot forward - what the funders' are looking for
Tue 19 15:30
YE Symposium: Maintaining your endocrine career despite what life throws at you
Young Endocrinologists' debate
Tue 19 16:00
TEA & COFFEE
HALL H
Tue 19 16:30
MTE4
Meet The Expert 4
Induced plurripotent stem cells as an endocrine tool
Tue 19 16:30
S8.1
Symposium 8: Non functioning pituitary tumours
Epidemiology and natural history of pituitary tumours
Birmingham, UK
Tue 19 17:00
S8.2
Symposium 8: Non functioning pituitary tumours
Pathological mechanisms underlying non-functioning pituitary tumours
Denver, USA
Tue 19 17:30
S8.3
Symposium 8: Non functioning pituitary tumours
Pathological markers of aggressive pituitary tumour behaviour - use of MGMT?
Ferrara, Italy
Tue 19 18:00
S8.4
Symposium 8: Non functioning pituitary tumours
Aggressive pituitary tumours and temozolomide treatment
Marseille, France
Tue 19 16:30
OC5.1
Oral Communications 5: Pituitary and neoplasia
Genetic background influences tumour phenotype in heterozygous Men1 knockout mice
Tue 19 16:45
OC5.2
Oral Communications 5: Pituitary and neoplasia
The role of the microRNA miR-34a in the regulation of aryl hydrocarbon receptor interacting protein (AIP)
Tue 19 17:00
OC5.3
Oral Communications 5: Pituitary and neoplasia
Whole-exome sequencing studies of non-functioning pituitary adenomas
Dundee, United Kingdom
Tue 19 17:15
OC5.4
Oral Communications 5: Pituitary and neoplasia
Clinical, metabolic, biochemical and radiological characterisation of patients with thyrotropinomas reveals a highly variable phenotype
Tue 19 17:30
OC5.5
Oral Communications 5: Pituitary and neoplasia
Densely and sparsely granulated somatotroph adenomas - clinical, genetic and histological differences
Tue 19 17:45
OC5.6
Oral Communications 5: Pituitary and neoplasia
Manipulating PBF/PTTG1IP phosphorylation status to improve radioiodine uptake in thyroid and other tumours
Tue 19 18:00
OC5.7
Oral Communications 5: Pituitary and neoplasia
Uterine tumours with loss of progesterone receptor expression develop in mice deleted for a Cell Division Cycle 73 (CDC73) allele
Tue 19 18:15
OC5.8
Oral Communications 5: Pituitary and neoplasia
Pituitary adenoma and phaeochromocytoma/paraganglioma - a novel syndrome with a heterogeneous genetic background
Tue 19 16:30
D1.1
Debate
FOR
Tue 19 17:00
D1.2
Debate
AGAINST
Tue 19 17:45
MTE5
Meet the Expert 5
Challenges in managing hyperthroidism in young people
Tue 19 19:30
Conference dinner
ROYAL HALL
Wed 20 07:00
BREAKFAST
QUEEN'S SUITE FOYER
Wed 20 07:15
MTE7
Meet the Expert 7
Hormone misuse in sport and leisure
Wed 20
MTE 6
Meet the Expert 6
Malignant Phaeochromocytoma
Wed 20 07:45
BREAKFAST
MAIN AUDITORIUM FOYER
Wed 20 08:10
ANNUAL GENERAL MEETING
MAIN AUDITORIUM
Wed 20 09:00
N1.1
Nurse Session 1: The Patient Pathway for Pituitary Care
Overview and workup
Wed 20 09:30
N1.2
Nurse Session 1: The Patient Pathway for Pituitary Care
Peri-operative care-surgical aspects
Wed 20 09:45
N1.3
Nurse Session 1: The Patient Pathway for Pituitary Care
The Surgery
Wed 20 10:15
N1.4
Nurse Session 1: The Patient Pathway for Pituitary Care
Radiotherapy and post operative management
Wed 20 10:45
N1.5
Nurse Session 1: The Patient Pathway for Pituitary Care
Post-operative and follow-up care
Wed 20 09:00
S10.1
Symposium 10: Lipodystrophy - The perils of being thin
Familial partial lipodystrophy: an introduction
Wed 20 09:30
S10.2
Symposium 10: Lipodystrophy - The perils of being thin
Novel genetic causes of partial lipdystrophy
Wed 20 10:00
S10.3
Symposium 10: Lipodystrophy - The perils of being thin
HIV and lipodystrophy
Barcelona, Spain
Wed 20 10:30
S10.4
Symposium 10: Lipodystrophy - The perils of being thin
Approach to lipodystrophy management - a new national service
Wed 20 09:00
S9.1
Symposium 9: Novel aspects of GPCR signalling
GPCR mutations and reproduction
Boston, USA
Wed 20 09:30
S9.2
Symposium 9: Novel aspects of GPCR signalling
Novel aspects of TSH receptor signalling
Bethesda, USA
Wed 20 10:00
S9.3
Symposium 9: Novel aspects of GPCR signalling
In vivo dimerization of LH receptors
Wed 20 10:30
S9.4
Symposium 9: Novel aspects of GPCR signalling
Allosteric LH receptor regulation
Saarbrucken, Germany
Wed 20 10:00
EW2.1
Education Workshop 2: How to get your research published
Endocrine Connections
Aarhus, Denmark
Wed 20 10:10
EW2.2
Education Workshop 2: How to get your research published
Endocrine-Related Cancer
Essen, Germany
Wed 20 10:20
EW2.3
Education Workshop 2: How to get your research published
Journal of Endocrinology
Wed 20 10:25
EW2.4
Education Workshop 2: How to get your research published
Journal of Molecular Endocrinology
Wed 20 10:30
EW2.5
Education Workshop 2: How to get your research published
Clinical Endocrinology
Wed 20 10:40
EW2.6
Education Workshop 2: How to get your research published
Question & answer session
Wed 20 11:00
TEA & COFFEE
HALL H
Wed 20
PL3
SfE European Medal Lecture
cAMP in the pituitary: An old messenger for multiple signals
Milan, Italy on behalf of the author group
Wed 20
PL4
SfE Translatlantic Medal Lecture
Environmental regulation of neuroendocrine systems through epigenetic mechanisms
Montreal, Canada
Wed 20 12:30
LUNCH
HALL H
Wed 20
Viropharma satellite symposium
Current challenges in the management of AI: why current therapy fails our patients
Birmingham, UK
Wed 20
Viropharma satellite symposium
Current challenges in the management of AI: goals of therapy
Wed 20
Viropharma satellite symposium
How a dual-release preparation can help overcome challenges
Gothenburg, Sweden
Wed 20
Viropharma satellite symposium
Panel
Wed 20 13:45
N2.1
Nurse Session 2: Late Effects
Pituitary late effects
Leeds, UK
Wed 20 14:25
N2.2
Nurse Session 2: Late Effects
Thyroid late effects
Wed 20 15:05
N2.3
Nurse Session 2: Late Effects
Gonadal late effects
London, UK
Wed 20 13:45
S12.1
Symposium 12: Thymic function and autoimmune endocrine disease
The thymus medulla, Aire, and autoimmunity
Wed 20 14:15
S12.2
Symposium 12: Thymic function and autoimmune endocrine disease
Anti-cytokine autoantibodies in AIRE deficient humans and mice
Wed 20 14:45
S12.3
Symposium 12: Thymic function and autoimmune endocrine disease
Attacking the endocrine system: what is AIRE doing?
Tokushima, Japan
Wed 20 15:15
S12.4
Symposium 12: Thymic function and autoimmune endocrine disease
Regulatory T cells, CTLA-4 and autoimmune disease
Wed 20 13:45
S11.1
Symposium 11: Guts, brains and bariatric surgery
How does bariatric surgery cure obesity?
Wed 20 14:15
S11.2
Symposium 11: Guts, brains and bariatric surgery
Gut-brain communication - Ghrelin
Gothenburg, Sweden
Wed 20 14:45
S11.3
Symposium 11: Guts, brains and bariatric surgery
Targeting gut hormone release to treat obesity
Wed 20 15:15
S11.4
Symposium 11: Guts, brains and bariatric surgery
Gut hormones: a cure for obesity
Wed 20
MTE8
Meet The Expert 8
Live Cell Imaging
Wed 20
MTE9
Meet The Expert 9
Biomedical mass spectrometry - moving forward
Edinburgh, UK
Wed 20 15:45
TEA & COFFEE
HALL H
Wed 20 16:15
Awards Ceremony
MAIN AUDITORIUM
Wed 20
PL5
BTA Pitt-Rivers Lecture
Regulation of Tissue-Specific Regulation of Thyroid Hormone Action
Miami, USA
Wed 20 16:45
EXHIBITION CLOSES
Wed 20
PL6
SfE Medal Lecture
Genes and Giants

Unknown speaker

London, UK
Thu 21 07:15
BREAKFAST
QUEEN'S SUITE FOYER
Thu 21 07:30
Meet The Expert 3 (Repeated)
QUEEN'S SUITE A
Thu 21 07:30
Meet The Expert 5 (Repeated)
QUEEN'S SUITE B
Thu 21
PL7
Clincal Endocrinology Trust Lecture
The dynamics of hypothalamic-pituitary-adrenal activity
Thu 21
PL8
Clinical Endocrinology Trust Visiting Professor Lecture
Evaluation of the adrenal cortex: Future possibilities
Bethesda, USA
Thu 21 09:30
CG1.1
Clinical Guidelines
Consequences of cancer therapy
Thu 21 09:45
CG1.2
Clinical Guidelines
Adults with CAH
Thu 21 10:00
TEA & COFFEE
MAIN AUDITORIUM & QUEEN'S SUITE FOYER
Thu 21 10:30
CMW4.1
Clinical Management Workshop 4: Managing Hypoglycaemia
Hypoglycaemia in diabetes - effects on cerebral and autonomic function
Thu 21 11:00
CMW4.2
Clinical Management Workshop 4: Managing Hypoglycaemia
Insulinoma - new developments in localisation and therapy
Rochester, USA
Thu 21 11:30
CMW4.3
Clinical Management Workshop 4: Managing Hypoglycaemia
Hypoglycaemia in neonates and children
Thu 21 12:00
CMW4.4
Clinical Management Workshop 4: Managing Hypoglycaemia
Autoimmune hypoglycaemia - when and how to look for anti-insulin and anti-insulin receptor antibodies
UK
Thu 21 10:30
CMW3.1
Clinical Management Workshop 3: PCOS - why, how and what
Consensus on women's health aspects of PCOS
Thu 21 11:00
CMW3.2
Clinical Management Workshop 3: PCOS - why, how and what
Treatment of PCOS in Non-Obese Adolescents
Barcelona, Spain
Thu 21 11:30
CMW3.3
Clinical Management Workshop 3: PCOS - why, how and what
Is there a place for Metformin in PCOS?
Hershey, USA
Thu 21 12:00
CMW3.4
Clinical Management Workshop 3: PCOS - why, how and what
Diagnosis and Management of hirsuitism
Madrid, Spain
Thu 21 12:30
Meet The Expert 1 (Repeated)
QUEEN'S SUITE A
Thu 21 12:30
Meet The Expert 2 (Repeated)
QUEEN'S SUITE B
Thu 21 13:30
Meet The Expert 6 (Repeated)
QUEEN'S SUITE A
Thu 21 13:30
Meet The Expert 7 (Repeated)
QUEEN'S SUITE B

0 result(s) found.